Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar:143:186-196.
doi: 10.1016/j.jclinepi.2021.10.023. Epub 2021 Nov 3.

Harms in Systematic Reviews Paper 1: An introduction to research on harms

Affiliations

Harms in Systematic Reviews Paper 1: An introduction to research on harms

Riaz Qureshi et al. J Clin Epidemiol. 2022 Mar.

Abstract

Objective: Most systematic reviews of interventions focus on potential benefits. Common methods and assumptions that are appropriate for assessing benefits can be inappropriate for harms. This paper provides a primer on researching harms, particularly in systematic reviews.

Study design and setting: Commentary describing challenges with assessing harm.

Results: Investigators should be familiar with various terminologies used to describe, classify, and group harms. Published reports of clinical trials include limited information about harms, so systematic reviewers should not depend on these studies and journal articles to reach conclusions about harms. Visualizations might improve communication of multiple dimensions of harms such as severity, relatedness, and timing.

Conclusion: The terminology, classification, detection, collection, and reporting of harms create unique challenges that take time, expertise, and resources to navigate in both primary studies and evidence syntheses. Systematic reviewers might reach incorrect conclusions if they focus on evidence about harms found in published reports of randomized trials of a particular health problem. Systematic reviews could be improved through better identification and reporting of harms in primary studies and through better training and uptake of appropriate methods for synthesizing evidence about harms.

Keywords: Clinical Trials; Harms; Meta-analysis; Synthesis; Systematic Reviews.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1.
Fig. 1.
MedDRA hierarchy for nausea.
Fig. 2.
Fig. 2.
Inconsistent selection criteria applied across different sources for the same trial.

References

    1. Qureshi R , Mayo-Wilson E , Li T . Summaries of harms in systematic reviews are unreliable Paper 1: An introduction to research on harms. J Clin Epidemiol 2021. (IN PRESS). - PMC - PubMed
    1. Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Summaries of harms in systematic reviews are unreliable Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin. J Clin Epidemiol 2021. (IN PRESS). - PMC - PubMed
    1. Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Summaries of harms in systematic reviews are unreliable Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms. J Clin Epidemiol 2021. (IN PRESS). - PMC - PubMed
    1. Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB. Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. J Clin Epidemiol 2018;93:9–24. doi:10.1016/j.jclinepi.2017.10.002. - DOI - PubMed
    1. Ioannidis JP, Evans SJ, Gøtzsche PC, O’Neill RT, Altman DG, Schulz K, et al. Improving patient care better reporting of harms in randomized trials : An extension of the CONSORT statement. Ann Intern Med 2004;141(10):781–8. doi:10.7326/0003-4819-141-10-200411160-00009. - DOI - PubMed

Publication types